Oct 26, 2026

  • Add News

Supreme Court questions govt over drug pricing, asks why cap limited to anti-cancer medicines

The Supreme Court expressed its worry over the government's restriction of price control measures to only anti-cancer drugs, questioning why other vital medications lack similar oversight when sold at exorbitant rates. The Solicitor General emphasized the importance of maintaining a balance between drug availability and market dynamics in determining prices.

RSS News
Economic times

0 thoughts on “Supreme Court questions govt over drug pricing, asks why cap limited to anti-cancer medicines”

Leave a Reply

Your email address will not be published. Required fields are marked *

We use cookies to ensure that we give you the best experience on our website. By continuing to browse our site we'll assume that you understand this. Learn more